222 related articles for article (PubMed ID: 1534179)
21. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
Fuller RW; Snoddy HD
Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
[TBL] [Abstract][Full Text] [Related]
22. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
23. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior.
Ahlenius S; Larsson K; Svensson L; Hjorth S; Carlsson A; Lindberg P; Wikström H; Sanchez D; Arvidsson LE; Hacksell U; Nilsson JL
Pharmacol Biochem Behav; 1981 Nov; 15(5):785-92. PubMed ID: 6458826
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
Berendsen HH; Broekkamp CL
Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
[TBL] [Abstract][Full Text] [Related]
25. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
27. Metachlorophenylpiperazine (m-CPP) induced intracavernous pressure responses in anaesthetized rats.
Hayes ES; Adaikan PG
Int J Impot Res; 2002 Aug; 14(4):287-94. PubMed ID: 12152119
[TBL] [Abstract][Full Text] [Related]
28. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat.
Bagdy G; Calogero AE; Aulakh CS; Szemeredi K; Murphy DL
Neuroendocrinology; 1989 Sep; 50(3):241-7. PubMed ID: 2552339
[TBL] [Abstract][Full Text] [Related]
29. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons.
Ahlers ST; Weissman BA; Barrett JE
J Pharmacol Exp Ther; 1992 Feb; 260(2):474-81. PubMed ID: 1531359
[TBL] [Abstract][Full Text] [Related]
30. 5HT-2 mediation of acute behavioral effects of hallucinogens in rats.
Wing LL; Tapson GS; Geyer MA
Psychopharmacology (Berl); 1990; 100(3):417-25. PubMed ID: 2138338
[TBL] [Abstract][Full Text] [Related]
31. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
32. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
[TBL] [Abstract][Full Text] [Related]
33. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
Jackson HC; Kitchen I
Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
[TBL] [Abstract][Full Text] [Related]
34. Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence.
Kleven M; Ybema C; Carilla E; Hamon M; Koek W
Eur J Pharmacol; 1995 Aug; 281(3):219-28. PubMed ID: 8521904
[TBL] [Abstract][Full Text] [Related]
35. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
Parsons AA; Motevalian M; Whalley ET
Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
[TBL] [Abstract][Full Text] [Related]
36. Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonists.
Kelly PA; Davis CJ; Goodwin GM
Neuroscience; 1988 Jun; 25(3):907-15. PubMed ID: 2970017
[TBL] [Abstract][Full Text] [Related]
37. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Yamada J; Sugimoto Y; Horisaka K
Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
[TBL] [Abstract][Full Text] [Related]
38. 5-HT1A and 5-HT1C/1D receptor agonists produce reciprocal effects on male sexual behavior of rhesus monkeys.
Pomerantz SM; Hepner BC; Wertz JM
Eur J Pharmacol; 1993 Oct; 243(3):227-34. PubMed ID: 8276074
[TBL] [Abstract][Full Text] [Related]
39. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
Krebs KM; Geyer MA
Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855
[TBL] [Abstract][Full Text] [Related]
40. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.
Pranzatelli MR; Pluchino RS
Pharmacol Biochem Behav; 1991 Jun; 39(2):407-13. PubMed ID: 1835098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
